Tuesday, August 26, 2014 8:14:48 AM
August 26, 2014 6:53 AM EDT
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $7 price target on Idera Pharmaceuticals (NASDAQ: IDRA)
http://www.streetinsider.com/Analyst+Comments/Idera+Pharmaceuticals+%28IDRA%29+Top+Small+Cap+Pick+for+2nd-Half+at+Piper+Jaffray/9781931.html
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM